Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EPS Growth

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year EPS Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EPS Growth(%) 169.73-605.16-68.44-2.9225.01

What is the latest EPS Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest EPS Growth ratio of GLENMARK PHARMACEUTICALS is 169.73 based on Mar2025 Consolidated results.
Year EPS Growth
Mar2025169.73
Mar2024-605.16
Mar2023-68.44
Mar2022-2.92
Mar202125.01

How is EPS Growth of GLENMARK PHARMACEUTICALS Trending?

Years EPS Growth % Change
Mar2025 169.73
Positive
Mar2024 -605.16
Negative
Mar2023 -68.44
Negative
Mar2022 -2.92
Negative
Mar2021 25.01 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EPS Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹58,818.9 Cr 3.2% 4.6% 50.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹108,703.0 Cr 1.3% 1.3% -9.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.2%

4.6%

50.6%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses